v3.26.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 139,220,208 $ 56,490,579
Marketable securities 39,543,820 41,052,949
Prepaid research and development 1,001,993 81,308
Prepaid expenses and other current assets 343,374 826,473
Total current assets 180,109,395 98,451,309
Equipment and improvements, net 0 47,100
Right-of-use asset 0 101,437
Prepaid research and development, noncurrent 1,000,000 0
Amount held as a retainer 95,121 0
Total assets 181,204,516 98,599,846
Current liabilities:    
Accounts payable 1,158,054 943,019
Lease obligation, current 0 110,517
Accrued expenses and other current liabilities 4,081,282 2,680,030
Contingent consideration liability 3,061,501 0
Total current liabilities 8,300,837 3,733,566
Total liabilities 8,300,837 3,733,566
Commitments and contingencies (see Note 15)
Stockholders' equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2025 and December 31, 2024 0 0
Common stock, $0.001 par value; 500,000,000 and 100,000,000 shares authorized; 131,691,237 and 69,362,439 shares issued and outstanding (including 4,149,252 and 0 contingently issuable shares - see Note 7) at December 31, 2025 and December 31, 2024, respectively 131,691 69,362
Additional paid-in capital 315,429,986 189,254,777
Accumulated other comprehensive income (loss) 21,802 (37,248)
Accumulated deficit (142,679,800) (94,420,611)
Total stockholders' equity 172,903,679 94,866,280
Total liabilities and stockholders' equity $ 181,204,516 $ 98,599,846

Source

PDF HTML 10-K Filing
ZIP HTML XBRL